GT200900235A - Composiciones farmaceuticas - Google Patents
Composiciones farmaceuticasInfo
- Publication number
- GT200900235A GT200900235A GT200900235A GT200900235A GT200900235A GT 200900235 A GT200900235 A GT 200900235A GT 200900235 A GT200900235 A GT 200900235A GT 200900235 A GT200900235 A GT 200900235A GT 200900235 A GT200900235 A GT 200900235A
- Authority
- GT
- Guatemala
- Prior art keywords
- pharmaceutical compositions
- compositions
- calcilitico
- osea
- troubling
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA PRESENTE INVENCION SE REFIERE A COMPOSICIONES FARMACEUTICAS, EN PARTICULAR A COMPOSICIONES PARA LA ADMINISTRACION ORAL DE UN CALCILITICO COMO UN AGENTE ACTIVO DE UTILIDAD EN CUADROS DE OSTEOPOROSIS, LA CUAL SE CARACTERIZA POR UNA BAJA MASA OSEA Y POR EL DETERIORO MICRO-ARQUITECTONICO DEL TEJIDO OSEO, QUE CONDUCE A FRAGILIDAD Y A MAYOR RIESGO DE FRACTURAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07103365A EP1964548A1 (en) | 2007-03-02 | 2007-03-02 | Pharmaceutical compositions comprising a calcilytic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200900235A true GT200900235A (es) | 2010-03-15 |
Family
ID=38016483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200900235A GT200900235A (es) | 2007-03-02 | 2009-08-31 | Composiciones farmaceuticas |
Country Status (20)
Country | Link |
---|---|
US (1) | US20100022565A1 (es) |
EP (2) | EP1964548A1 (es) |
JP (1) | JP2010520179A (es) |
KR (1) | KR20090125245A (es) |
CN (1) | CN101621993A (es) |
AR (1) | AR065564A1 (es) |
AU (1) | AU2008223876A1 (es) |
CA (1) | CA2678794A1 (es) |
CL (1) | CL2008000617A1 (es) |
CO (1) | CO6210808A2 (es) |
EC (1) | ECSP099611A (es) |
GT (1) | GT200900235A (es) |
IL (1) | IL200274A0 (es) |
MA (1) | MA31201B1 (es) |
MX (1) | MX2009009343A (es) |
PE (1) | PE20081794A1 (es) |
TN (1) | TN2009000358A1 (es) |
TW (1) | TW200843762A (es) |
WO (1) | WO2008107390A1 (es) |
ZA (1) | ZA200905472B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0606426D0 (en) * | 2006-03-30 | 2006-05-10 | Novartis Ag | Benzimidazole derivatives |
MX2009003673A (es) | 2006-10-04 | 2009-04-22 | Pfizer Prod Inc | Derivados de piridido[4,3-d]pirimidin-4(3h)-ona como antagonistas de los receptores de calcio. |
US9073294B2 (en) | 2013-06-04 | 2015-07-07 | Monosol, Llc | Method for sealing a water-soluble film by applying a sealing solution |
CN109640958B (zh) * | 2016-05-20 | 2022-11-22 | 蔚蓝生物技术股份有限公司 | 包含选择性雌激素受体调节剂(serm)的阴道递送系统及其用途 |
JP6994061B2 (ja) | 2019-02-15 | 2022-01-14 | ノバルティス アーゲー | 4-(7-ヒドロキシ-2-イソプロピル-4-オキソ-4h-キナゾリン-3-イル)-ベンゾニトリルの製剤 |
WO2021029517A1 (en) * | 2019-08-13 | 2021-02-18 | Dongguk University Industry-Academic Cooperation Foundation | Pharmaceutical composition for improving or treating post-surgical hypoparathyroidism and treatment method using the same |
KR102220255B1 (ko) * | 2019-08-13 | 2021-02-26 | 동국대학교 산학협력단 | 수술 후 부갑상선기능저하증 개선 또는 치료용 약학 조성물 및 이를 이용한 치료 방법 |
KR20230106582A (ko) * | 2020-08-04 | 2023-07-13 | 캘시리틱스 테라퓨틱스, 인코포레이티드 | 트리페닐 칼실리틱 화합물의 제형 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7202261B2 (en) * | 1996-12-03 | 2007-04-10 | Nps Pharmaceuticals, Inc. | Calcilytic compounds |
PE20001456A1 (es) * | 1999-02-02 | 2001-01-28 | Smithkline Beecham Corp | Compuestos calcioliticos |
JP2006512315A (ja) * | 2002-11-04 | 2006-04-13 | エヌピーエス ファーマスーティカルズ インコーポレイテッド | カルシリティックとしてのキナゾリノン化合物 |
-
2007
- 2007-03-02 EP EP07103365A patent/EP1964548A1/en not_active Ceased
-
2008
- 2008-02-29 TW TW097107238A patent/TW200843762A/zh unknown
- 2008-02-29 EP EP08717280A patent/EP2124893A1/en not_active Withdrawn
- 2008-02-29 CL CL200800617A patent/CL2008000617A1/es unknown
- 2008-02-29 CA CA002678794A patent/CA2678794A1/en not_active Abandoned
- 2008-02-29 MX MX2009009343A patent/MX2009009343A/es not_active Application Discontinuation
- 2008-02-29 AU AU2008223876A patent/AU2008223876A1/en not_active Abandoned
- 2008-02-29 JP JP2009551224A patent/JP2010520179A/ja active Pending
- 2008-02-29 PE PE2008000407A patent/PE20081794A1/es not_active Application Discontinuation
- 2008-02-29 WO PCT/EP2008/052500 patent/WO2008107390A1/en active Application Filing
- 2008-02-29 KR KR1020097018235A patent/KR20090125245A/ko not_active Application Discontinuation
- 2008-02-29 AR ARP080100861A patent/AR065564A1/es unknown
- 2008-02-29 CN CN200880006503A patent/CN101621993A/zh active Pending
- 2008-02-29 US US12/529,359 patent/US20100022565A1/en not_active Abandoned
-
2009
- 2009-08-05 ZA ZA200905472A patent/ZA200905472B/xx unknown
- 2009-08-06 IL IL200274A patent/IL200274A0/en unknown
- 2009-08-28 TN TNP2009000358A patent/TN2009000358A1/fr unknown
- 2009-08-28 CO CO09091220A patent/CO6210808A2/es not_active Application Discontinuation
- 2009-08-31 MA MA32187A patent/MA31201B1/fr unknown
- 2009-08-31 GT GT200900235A patent/GT200900235A/es unknown
- 2009-09-01 EC EC2009009611A patent/ECSP099611A/es unknown
Also Published As
Publication number | Publication date |
---|---|
MA31201B1 (fr) | 2010-02-01 |
EP1964548A1 (en) | 2008-09-03 |
EP2124893A1 (en) | 2009-12-02 |
US20100022565A1 (en) | 2010-01-28 |
ZA200905472B (en) | 2010-04-28 |
TN2009000358A1 (en) | 2010-12-31 |
IL200274A0 (en) | 2010-04-29 |
JP2010520179A (ja) | 2010-06-10 |
AR065564A1 (es) | 2009-06-17 |
PE20081794A1 (es) | 2009-01-09 |
CN101621993A (zh) | 2010-01-06 |
MX2009009343A (es) | 2009-09-11 |
ECSP099611A (es) | 2009-10-30 |
AU2008223876A1 (en) | 2008-09-12 |
CO6210808A2 (es) | 2010-10-20 |
CL2008000617A1 (es) | 2008-09-12 |
CA2678794A1 (en) | 2008-09-12 |
WO2008107390A1 (en) | 2008-09-12 |
TW200843762A (en) | 2008-11-16 |
KR20090125245A (ko) | 2009-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200900235A (es) | Composiciones farmaceuticas | |
HN2011003011A (es) | Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas | |
UY32923A (es) | Compuestos policíclicos como antagonistas del receptor de ácido lisofosfatídico | |
MD4577B1 (ro) | Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare | |
CO6670567A2 (es) | Métodos de tratamiento contra el cáncer pancreático | |
UY28862A1 (es) | Nuevas composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii | |
BRPI0925036B8 (pt) | uso de trans-t-butil ciclo-hexanol, composição cosmética, medicamento, seus usos e processos para tratar irritação na pele | |
UY35040A (es) | Pirrolopirimidinilamino-benzotiazolonas sustituidas | |
AR081681A1 (es) | METODOS Y COMPOSICIONES PARA LA ADMINISTRACION INTRATECAL DE b-GALACTOCEREBROSIDASA | |
AR070888A1 (es) | Composiciones farmaceuticas con buena biodisponibilidad | |
HN2010002518A (es) | Composicion farmaceutica que comprende una sal de estroncio, vitamina d y una ciclodextrina | |
PE20121495A1 (es) | Combinacion de un agente quimioterapeutico y un inhibidor del sistema tgf-beta | |
TR200900878A2 (tr) | Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar | |
UY31780A (es) | Fenoxibenzamidas sustituidas | |
CO6650354A2 (es) | Composiciones farmacéuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3[6-(4-metil-piperazin-1-il)-1h-bendimidazol-2-il]-1h-quinolin-2-ona | |
AR081082A1 (es) | Composiciones organicas para tratar enfermedades relacionadas con beta-enac | |
UY32457A (es) | Vacuna del virus del dengue inactivado | |
ECSP14013200A (es) | Una nueva composición terapéutica que contiene apomorfina como principio activo | |
UY35848A (es) | Tienopirimidinas | |
CO6551731A2 (es) | Composiciòn de combinaciòn que comprende como ingrediente activo l- carnitina o propionil l- carnitina, para la prevenciòn o tratamiento de insuficienca venosa crònica | |
CR20110190A (es) | Agente rodenticida sinérgico | |
AR091739A1 (es) | Composiciones y metodos para reducir el riesgo cardiometabolico | |
TR200900879A2 (tr) | Aktif maddelerin tek bir dozaj formunda kombine edildiği farmasötik bileşimler | |
BR112015011693A2 (pt) | composições fibrinolíticas compreendendo bromelina e nattokinase para a prevenção e tratamento de estados flebotrombóticos | |
AR055658A1 (es) | Composiciones fungicidas |